[Renal cell carcinoma].
Hirie
Shigero
S
Department of Urology, Teikyo Univ. School of Medicine, Tokyo, Japan
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D009362:Neoplasm Metastasis / Q000473:pathology; D015513:Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D011379:Prognosis; D015398:Signal Transduction; D015996:Survival Rate; D019139:Tumor Escape / Q000276:immunology
D000970:Antineoplastic Agents; D015513:Oncogene Proteins